Cargando…

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea

BACKGROUND: Irritable bowel syndrome with diarrhoea (IBS-D) is particularly debilitating due to urgency and episodic incontinence. Some 5-hydroxytryptamine 3 (5-HT3) receptor antagonists (5-HT3RAs) have proven effective but have serious side effects. Ondansetron, also a 5-HT3RA, has been widely used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garsed, Klara, Chernova, Julia, Hastings, Margaret, Lam, Ching, Marciani, Luca, Singh, Gulzar, Henry, Amanda, Hall, Ian, Whorwell, Peter, Spiller, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Neurogastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173656/ https://www.ncbi.nlm.nih.gov/pubmed/24334242 http://dx.doi.org/10.1136/gutjnl-2013-305989

Ejemplares similares

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Abnormalities of mucosal serotonin metabolism and 5‐HT(3) receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron
por: Gunn, David, et al.
Publicado: (2019)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
por: Savarino, Edoardo, et al.
Publicado: (2022)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
por: Everitt, Hazel Anne, et al.
Publicado: (2019)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
por: McPherson, Zachary E., et al.
Publicado: (2021)

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations
por: Tornkvist, Navkiran T., et al.
Publicado: (2022)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
por: Akbar, A, et al.
Publicado: (2008)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
por: Seeling, Katharina Sophie, et al.
Publicado: (2023)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
por: van Assen, Tijmen, et al.
Publicado: (2012)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies
por: Gunn, David, et al.
Publicado: (2022)

Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
por: Gunn, David, et al.
Publicado: (2019)

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
por: Martínez, Cristina, et al.
Publicado: (2017)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Randomised controlled trial of mesalazine in IBS
por: Barbara, Giovanni, et al.
Publicado: (2016)

Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study
por: Manabe, Noriaki, et al.
Publicado: (2023)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013)

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
por: Matsueda, Kei, et al.
Publicado: (2011)

Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus
por: Tsuchida, Yasuaki, et al.
Publicado: (2010)

Mechanisms of activation of mouse and human enteroendocrine cells by nutrients
por: Symonds, Erin L, et al.
Publicado: (2015)

Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1
por: Zhou, QiQi, et al.
Publicado: (2016)

Apelin targets gut contraction to control glucose metabolism via the brain
por: Fournel, Audren, et al.
Publicado: (2017)

Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation
por: Su, Andrew, et al.
Publicado: (2016)

Ex vivo study of human visceral nociceptors
por: McGuire, Cian, et al.
Publicado: (2018)

Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis
por: Paulon, Emma, et al.
Publicado: (2017)

Irf4-dependent CD103(+)CD11b(+) dendritic cells and the intestinal microbiome regulate monocyte and macrophage activation and intestinal peristalsis in postoperative ileus
por: Pohl, Judith-Mira, et al.
Publicado: (2017)

Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons
por: Stakenborg, Nathalie, et al.
Publicado: (2019)

Single-cell RNAseq reveals seven classes of colonic sensory neuron
por: Hockley, James R F, et al.
Publicado: (2019)

Changes in neuromuscular structure and functions of human colon during ageing are region-dependent
por: Broad, John, et al.
Publicado: (2019)

α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABA(B) receptors
por: Castro, Joel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6i2v9pvnqed98dbjb3ehdu3rrn